# IBK Capital

> IBK Capital is a VC fund in Seoul backing Health Care, Biotechnology and Information Technology. See 115 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Seoul, South Korea
- Total investments: 115
- Last investment: Jul 2026
- Lead investor: 5%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/ibkc
- Website: https://www.ibkc.co.kr

IBK Capital is a VC fund in Seoul focused on Health Care and Biotechnology. IBK Capital is the venture capital arm of the Industrial Bank of Korea (IBK).

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $2k–$4M |
| Series A | $1.5M–$9.8M |
| Series B | $12k–$22M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 18 | 16% |
| Biotechnology | 15 | 13% |
| Information Technology | 13 | 11% |
| Medical | 11 | 10% |
| Software | 10 | 9% |

142 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 37 | 32% |
| Seed | 30 | 26% |
| Series B | 19 | 17% |
| Venture - Series Unknown | 10 | 9% |
| Series C | 8 | 7% |

7 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| South Korea | 103 | 90% |
| United States | 2 | 2% |
| India | 1 | 1% |
| Singapore | 1 | 1% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| MID | MID specializes in the development, testing, and production of space-related components. | $10.8M | Series A | Jul 29, 2026 |  |
| FNCT Biotech | FNCT Biotech develops antibody therapeutics for treating idiopathic pulmonary fibrosis (IPF). To create antibodies that target the underlying cause of IPF, the company's platform uses genetic engineering, providing patients with this medical need with a new treatment option. | $14M | Series B | Jun 16, 2026 |  |
| Automata | Automata creates AI-powered tools like AI agents and smart integrations that simplify how teams plan, communicate, and work. The company solves business problems by enabling AI to build, manage, and evolve software workflows while humans guide the AI to deliver real value.Automata provides industry-tailored AI solutions | $7.1M | Series A | Apr 24, 2026 |  |
| PEOPLE & TECHNOLOGY | PEOPLE AND TECHNOLOGY provides DX-based AI solutions on INDOOR GEOLOCATION AND SMART SENSING through its INDOORPLUS+ IoT, Location Based System (LBS) and Real Time Location System (RTLS) platform in the fields of healthcare, manufacturing, defense, smart cities, and the public sector.More than 100 corporate customers in various business sectorssuch as healthcare, banking, manufacturing, retail, energy and public services have already chosen PEOPLE AND TECHNOLOGY to deploy industry grade solutions for employee safety, asset tracking & monitoring, security & access control, flow management and process efficiency. They have gained improvements in productivity and process efficiency while reducing their corporate risks and optimizing their procurement. Since its foundation in 2013, PEOPLE AND TECHNOLOGY has become a leading provider in South Korea and is expanding overseas. | $9.9M | Venture - Series Unknown | Apr 07, 2026 |  |
| Willog | As a fast-growing startup, Willog provides a “item-level condition monitoring” that innovates the supply chain of sensitive, perishable or valuable goods where condition monitoring is required, and its efforts are to create a transparent and connected logistics flow. Based on its patented sensor technology and its cloud-based software, Willog helpscompanies gain seamless visibility down to the item-level and control over their shipments across their supply chain so they can have condition foresights and insights to improve their bottom line.Willog acquired 25 enterprise customers including MNCs like Hyundai Motor Group and DHL Express since its establishment. Willog is rapidly expanding its presence in various industries including bio-pharmaceutical, fresh food, and special logistics, where condition monitoring is key to business continuity. Going forward, while strengthening its leadership position in Korea, Willog will accelerate global expansion with partnerships in America, Kazakhstan, and Malaysia. |  | Series B | Feb 03, 2026 |  |
| PersonaAI | Persona AI is a Korean artificial intelligence company that develops its own NLP-based conversational AI engine and AI contact center (AICC) solutions for businesses. It provides enterprise AI services such as chatbots, callbots, and automation platforms designed to improve customer communication and support operations. The company focuses onbuilding scalable AI infrastructure including edge AI and generative AI tools used across industries like healthcare, finance, and customer service. | $8.3M | Venture - Series Unknown | Feb 02, 2026 |  |
| Open Asset | Open Asset enables financial institutions to rapidly and effectively implement blockchain technology and exchange token assets. |  |  | Feb 02, 2026 |  |
| KODA | KODA provides business and institutional customers with digital asset storage services. | $6.8M | Series A | Nov 26, 2025 |  |
| RebuilderAI | RebuilderAI is a 3D AI vision technology company for manufacturing, design, gaming, and entertainment. | $3.1M | Seed | Nov 13, 2025 |  |
| FUST Lab | First Lab designs and manufactures ultrasonic equipment for various industries, including nano emulsification/dispersion, non-surface-forming materials, protein extraction, and water treatment. They research and develop innovative nano materials and processing technologies, producing high-quality, uniform materials and efficiently treatingtoxic substances. | $2.1M | Seed | Nov 07, 2025 |  |

10 of 115 investments shown.

## Co-investors
- [Partners Investment](https://shizune.co/investors/profile/partners-investment) — VC Fund, 9 deals together
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund, 8 deals together
- [Korea Investment Partners](https://shizune.co/investors/profile/korea-investment-partners) — VC Fund, 8 deals together
- [Medici Investment](https://shizune.co/investors/profile/medici-investment-82c1) — VC Fund, 8 deals together
- [KB Investment](https://shizune.co/investors/profile/kbinvest) — VC Fund, 7 deals together
- [Kiwoom Investment](https://shizune.co/investors/profile/kiwoom-investment) — VC Fund, 7 deals together

## Similar investors

### Similar industry
- [SVG Ventures](https://shizune.co/investors/profile/svg-ventures) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Omnivore](https://shizune.co/investors/profile/omnivore-partners) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Strong Ventures](https://shizune.co/investors/profile/strong-ventures) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund
- [Kakao Ventures](https://shizune.co/investors/profile/kakao-ventures) — VC Fund

## Featured in investor lists
- [All VC Funds in South Korea](https://shizune.co/investors/vc-funds-south-korea)
- [All Investors in South Korea](https://shizune.co/investors/investors-south-korea)
- [SaaS Investors in South Korea](https://shizune.co/investors/saas-investors-south-korea)
- [SaaS VC Funds in South Korea](https://shizune.co/investors/saas-vc-funds-south-korea)
- [Enterprise Investors in South Korea](https://shizune.co/investors/enterprise-investors-south-korea)
- [Enterprise VC Funds in South Korea](https://shizune.co/investors/enterprise-vc-funds-south-korea)

## FAQ

### What does IBK Capital invest in?

IBK Capital invests primarily in Health Care, Biotechnology and Information Technology startups, most often at Series A and Seed stage. Most of the 115 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is IBK Capital's check size?

IBK Capital typically joins rounds of $2k–$4M at Seed, $1.5M–$9.8M at Series A and $12k–$22M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds IBK Capital participates in.

### When did IBK Capital last invest?

The most recent investment recorded for IBK Capital closed in Jul 2026. Shizune tracks 115 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co